Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.4.3 (
phospholipase C
)
18,461
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Myelin-associated glycoprotein
(
MAG
) is a myelin-specific cell adhesion molecule of the immunoglobulin supergene family and is tyrosine-phosphorylated in the developing brain. To define the role of
MAG
in signal transduction, the tyrosine phosphorylation sites were analyzed. The major tyrosine phosphorylation residue was identified as Tyr-620, which was found to interact specifically with the SH2 domains of
phospholipase C
(PLC gamma). This domain may represent a novel protein binding motif that can be regulated by tyrosine phosphorylation.
MAG
also specifically bound the Fyn tyrosine kinase, suggesting that
MAG
serves as a docking protein that allows the interaction between different signaling molecules.
...
PMID:Identification of tyrosine 620 as the major phosphorylation site of myelin-associated glycoprotein and its implication in interacting with signaling molecules. 752 50
Myelin-associated glycoprotein
(
MAG
), a protein expressed on the innermost wrap of myelin, contributes to long-term axon stability as evidenced by progressive axon degeneration in Mag-null mice. Recently,
MAG
was also found to protect axons from acute toxic insults. In the current study, rat dorsal root ganglion neurons were cultured on control substrata and substrata adsorbed with myelin proteins. Neurons on myelin-adsorbed surfaces were resistant to acute degeneration of neurites induced by vincristine, a cancer chemotherapeutic agent with neuropathic side effects. Myelin-mediated protection was reversed by anti-
MAG
antibody and was absent when cells were cultured on extracts from Mag-null mouse myelin, confirming the protective role of
MAG
. Gangliosides (sialylated glycosphingolipids) are one functional class of axonal receptors for
MAG
. In the current studies, a direct role for gangliosides in mediating the acute protective effects of
MAG
was established. Treatment of neurons with sialidase, an enzyme that cleaves the terminal sialic acids required for
MAG
binding, reversed
MAG
's protective effect, as did treatment with (1R,2R)-1-phenyl-2-hexadecanoylamino-3-pyrrolidino-1-propanol, an inhibitor of glycosphingolipid biosynthesis. In contrast, treatment with phosphatidylinositol-specific
phospholipase C
, an enzyme that cleaves Nogo receptors (NgR, another class of
MAG
receptor), or with a peptide inhibitor of an NgR-associated signaling molecule p75(NTR), failed to diminish
MAG
-mediated protection. Inhibiting the Rho-associated protein kinase ROCK reversed protection. We conclude that
MAG
protects neurites from acute toxic insult via a ganglioside-mediated signaling pathway that involves activation of RhoA. Understanding
MAG
-mediated protection may provide opportunities to reduce axonal damage and loss.
...
PMID:Myelin-associated glycoprotein (MAG) protects neurons from acute toxicity using a ganglioside-dependent mechanism. 2043 25